Viive M Howell - JoVE Visualize

Showing results (51-60 of 55) with videos related to

Pageof 6

Sort By:

You have reached the last page of results.This site can display upto 55 results.

International Journal of Molecular Sciences|January 11, 2018

Biodistribution and Clearance of Stable Superparamagnetic Maghemite Iron Oxide Nanoparticles in Mice Following Intraperitoneal AdministrationBinh T T Pham, Emily K Colvin, Nguyen T H Pham, et al.

Oncotarget|November 18, 2015

Connective tissue growth factor as a novel therapeutic target in high grade serous ovarian cancerKim Moran-Jones, Brian S Gloss, Rajmohan Murali, et al.

The Oncologist|June 20, 2020

ALK-Rearranged Non-Small Cell Lung Cancer in 2020: Real-World Triumphs in an Era of Multigeneration ALK-Inhibitor Sequencing Informed by Drug Resistance ProfilingMalinda Itchins, Brandon Lau, Amanda L Hudson, et al.

Cancer Research|October 20, 2004

Gene expression of parathyroid tumors: molecular subclassification and identification of the potential malignant phenotypeCarola J Haven, Viive M Howell, Paul H C Eilers, et al.

Cancers|September 28, 2021

Elevating CDCA3 Levels Enhances Tyrosine Kinase Inhibitor Sensitivity in TKI-Resistant EGFR Mutant Non-Small-Cell Lung CancerKatherine B Sahin, Esha T Shah, Genevieve P Ferguson, et al.

Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:

Pageof 6

You have reached the last page of results.This site can display upto 55 results.

International Journal of Molecular Sciences|January 11, 2018

Biodistribution and Clearance of Stable Superparamagnetic Maghemite Iron Oxide Nanoparticles in Mice Following Intraperitoneal AdministrationBinh T T Pham, Emily K Colvin, Nguyen T H Pham, et al.

Oncotarget|November 18, 2015

Connective tissue growth factor as a novel therapeutic target in high grade serous ovarian cancerKim Moran-Jones, Brian S Gloss, Rajmohan Murali, et al.

The Oncologist|June 20, 2020

ALK-Rearranged Non-Small Cell Lung Cancer in 2020: Real-World Triumphs in an Era of Multigeneration ALK-Inhibitor Sequencing Informed by Drug Resistance ProfilingMalinda Itchins, Brandon Lau, Amanda L Hudson, et al.

Cancer Research|October 20, 2004

Gene expression of parathyroid tumors: molecular subclassification and identification of the potential malignant phenotypeCarola J Haven, Viive M Howell, Paul H C Eilers, et al.

Cancers|September 28, 2021

Elevating CDCA3 Levels Enhances Tyrosine Kinase Inhibitor Sensitivity in TKI-Resistant EGFR Mutant Non-Small-Cell Lung CancerKatherine B Sahin, Esha T Shah, Genevieve P Ferguson, et al.

Pageof 6